2026 half year results
Today's results reinforce that Medibank is a growing health company, with our customers increasingly recognising the value and health and wellbeing support we provide.
Full Year Results FY16
Group NPAT of $417.6 million, up 46.4% from $285.3 million in FY15. Final dividend of 6.0 cents per share, fully franked
Medibank announces reporting issue will impact the release of tax statements to the majority of customers
As Medibank nears completion of a major technology upgrade, it is experiencing a reporting issue likely prevent it from providing annual tax statements to a majority of customers by July 15.
Medibank response to ACCC proceedings
Medibank is committed to acting in the best interests of our members and refutes claims by the ACCC related to activities that took place in 2014.
2026 half year results
Today's results reinforce that Medibank is a growing health company, with our customers increasingly recognising the value and health and wellbeing support we provide.
Full Year Results FY16
Group NPAT of $417.6 million, up 46.4% from $285.3 million in FY15. Final dividend of 6.0 cents per share, fully franked
Medibank announces reporting issue will impact the release of tax statements to the majority of customers
As Medibank nears completion of a major technology upgrade, it is experiencing a reporting issue likely prevent it from providing annual tax statements to a majority of customers by July 15.
Medibank response to ACCC proceedings
Medibank is committed to acting in the best interests of our members and refutes claims by the ACCC related to activities that took place in 2014.